Decisively, the latest molecular analyses do not report FHIT among the significantly mutated genes in ccRCC (Cancer Genome Atlas Research et al. 2013; Sato et al. 2013), suggesting it does not drive ccRCC progression. Here, FHIT is linked to nonpapillary renal cell carcinoma.